Deciphera Pharmaceuticals competitors and similar companiesClear all

Deciphera Pharmaceuticals's competitors and similar companies include Exelixis, Celldex Therapeutics, Bristol-Myers Squibb, Blueprint Medicines and Arog Pharmaceuticals.

	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.	Exelixis Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.	Celldex Therapeutics Celldex Therapeutics (formerly known as Avant Immunotherapeutics) is developing targeted therapeutics to address devastating diseases.	Bristol-Myers Squibb Bristol-Myers Squibb is a company that provides biopharmaceutical products.	Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.	Arog Pharmaceuticals Arog Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need.
Founding Date	Founding Date 2003	Founding Date 1994	Founding Date 1983	Founding Date 1887	Founding Date 2011	Founding Date 2010
Type	Type Public	Type Public	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare drug development life sciences oncology	Tags Healthcare biotech life sciences pharma
Locations	Locations Waltham, US HQ Lawrence, US	Locations Alameda, US HQ	Locations Hampton, US HQ Fall River, US Needham, US New Haven, US	Locations New York, US HQ Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR Montréal, CA Shanghai, CN see more	Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH	Locations Plano, US HQ
Employees	Employees 35037% increase	Employees 61727% increase	Employees 1327% increase	Employees 32,2006% increase	Employees 49515% increase	Employees 910% decrease
Valuation ($)	Valuation ($) 1.1 b	Valuation ($) 5.7 b	Valuation ($) 2 b	Valuation ($) 141.6 b	Valuation ($) 2.7 b	Valuation ($) N/A
Twitter followers	Twitter followers 748	Twitter followers 5.8 k	Twitter followers N/A	Twitter followers 157.5 k	Twitter followers 2.7 k	Twitter followers N/A
Number of tweets (last 30 days)	Number of tweets (last 30 days) 4	Number of tweets (last 30 days) 7	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 26	Number of tweets (last 30 days) 13	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 4.3	Average likes per tweet (last 30 days) 1.4	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 9.4	Average likes per tweet (last 30 days) 4.9	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 71.43%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 92.31%	Percentage of tweets with engagement (last 30 days) N/A
Employee Rating	Employee Rating 3.7	Employee Rating 2.7	Employee Rating 3.9	Employee Rating 3.9	Employee Rating 4.2	Employee Rating 1.8
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.6b (FY, 2022)	Revenue (est.) $2.4m (FY, 2022)	Revenue (est.) $46.2b (FY, 2022)	Revenue (est.) $204m (FY, 2022)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $57.9m (FY, 2022)	Cost of goods $100k (FY, 2022)	Cost of goods $10.1b (FY, 2022)	Cost of goods $17.8m (FY, 2022)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $1.6b (FY, 2022)	Gross profit $2.3m (FY, 2022)	Gross profit $36b (FY, 2022)	Gross profit $186.2m (FY, 2022)	Gross profit N/A
Net income	Net income ($25.9m) (FY, 2016)	Net income $182.3m (FY, 2022)	Net income ($113m) (FY, 2022)	Net income $6.3b (FY, 2022)	Net income ($557.5m) (FY, 2022)	Net income ($11.6m) (FY, 2017)
Funding
Total funding raised	Total funding raised $ 714m	Total funding raised N/A	Total funding raised $ 2m	Total funding raised $ 15.5m	Total funding raised $ 1.7b	Total funding raised N/A